Results 41 to 50 of about 3,878,916 (126)
Fixed-drug eruption: A retrospective study in a single referral center in northern Taiwan
Dermatologica Sinica, 2012 Background/Objective: Fixed drug eruption (FDE) is a dermatosis characterized by recurrent patches or plaques at exactly the same sites with each administration of the causative drug.
Cheng-Han Lee +4 more
doaj +1 more source
Acta Dermato-Venereologica, 2020 Bullous drug eruptions are infrequent, but because they pose a challenge both to affected patients and to treating physicians they are considered to be the most severe cutaneous adverse reactions (SCAR).
Maja Mockenhaupt
doaj +1 more source
Generalized bullous pigmented fixed drug eruption
, 2021 Las erupciones medicamentosas fijas son reacciones que pueden tener un curso benigno o producir una emergencia potencialmente mortal. Se manifiestan usual-mente dos días después de la administración de medicamentos, como máculas oscuras ...
Giraldo, Lucía +3 more
core
Dermatologic Toxicities Associated With Novel Pan‐RAS/RAF Inhibitors
Journal of Cutaneous Pathology, Volume 53, Issue 11, Page 1042-1050, November 2026.ABSTRACT Background The mitogen‐activated protein kinase (MAPK) pathway plays a key role in cell‐cycle regulation and tumor progression in cancer. Dermatologic toxicities (DTs) to newer pan‐RAS (RMC‐6236) and pan‐RAF (LXH254/naporafenib) inhibitors are emerging.
Lin J. He +11 more
wiley +1 more source
Emerging Paediatric Uses of Dupilumab Beyond Approvals
Clinical &Experimental Allergy, Volume 56, Issue 10, Page 1162-1176, October 2026.Dupilumab, through IL‐4Rα blockade, shows promising efficacy beyond approved indications in paediatric diseases driven by T2 inflammation. Emerging evidence—mainly from small studies—supports improvements in disease severity and quality of life, highlighting its potential as a targeted, steroid‐sparing therapy while underscoring the need for ...
Simone Foti Randazzese +11 more
wiley +1 more source
Bullous fixed-drug eruption with intraoral lesions due to mefenamic acid: A case report
, 2023 Bullous Fixed drug eruption (BFDE) is a form of skin and mucocutaneous allergic reaction formed as purplish plaque or bullae with purple base in the same previous place due to certain medication.
Anis Puspita Utami +4 more
core +1 more source
Cancer Medicine, Volume 15, Issue 9, September 2026.ABSTRACT Background T‐cell–engaging bispecific antibodies are increasingly utilised in haematological malignancies and are beginning to be adopted in solid‐tumour treatment protocols. Cytokine release syndrome and neurotoxicity are well recognised, but target‐specific dermatological adverse event reporting patterns remain poorly defined.
Saikat Mandal +2 more
wiley +1 more source
Drug induced bullous fixed drug eruption: a case report [PDF]
Bullous fixed drug eruption, which is a cutaneous adverse drug reaction, is commonly seen with antimicrobials and analgesics. Bullous drug eruptions are infrequent, but because they pose a challenge both to affected patients and to treating physicians ...
Emperumal, Tamil Selvi
core +1 more source
Toxic epidermal necrolysis and Stevens-Johnson syndrome
Orphanet Journal of Rare Diseases, 2010 Toxic epidermal necrolysis (TEN) and Stevens Johnson Syndrome (SJS) are severe adverse cutaneous drug reactions that predominantly involve the skin and mucous membranes.
French Lars E, Harr Thomas
doaj +1 more source
Clinical &Experimental Allergy, Volume 56, Issue 9, Page 1017-1030, September 2026.Most reactions are toxic–irritant, driven by epithelial injury and neuro‐inflammatory activation. IgE‐mediated allergy is less common but may cause immediate systemic reactions. Endotype differentiation guides diagnosis, risk stratification and management.
Prasad Dasari +9 more
wiley +1 more source